Felicity E. B. May

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Biology and Biochemistry D-index 54 Citations 7,844 120 World Ranking 11264 National Ranking 878

Overview

What are the main themes of her work throughout her whole career to date

Felicity E. B. May performs integrative Breast cancer and Mammary gland research in her work. In her work, she performs multidisciplinary research in Mammary gland and Breast cancer. Felicity E. B. May merges Staining with Immunohistochemistry in her research. Her work often combines Immunohistochemistry and Cancer studies. Cancer is closely attributed to Internal medicine in her work. In most of her Internal medicine studies, her work intersects topics such as Lymph node. Her Pathology research extends to Lymph node, which is thematically connected. Her Pathology study typically links adjacent topics like Stain. Her Stain study typically links adjacent topics like Staining.

Felicity E. B. May most often published in these fields:

Breast cancer (50.00%)
Staining (50.00%)
Pathology (50.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

ROLE OF INSULIN-LIKE GROWTH FACTORS AND THE TYPE I INSULIN-LIKE GROWTH FACTOR RECEPTOR IN THE ESTROGEN-STIMULATED PROLIFERATION OF HUMAN BREAST CANCER CELLS

A. J. Stewart;M. D. Johnson;F. E. B. May;B. R. Westley.
Journal of Biological Chemistry (1990)

446 Citations

Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis.

Colm Hennessy;James A. Henry;Felicity E. B. May;Bruce R. Westley.
Journal of the National Cancer Institute (1991)

396 Citations

The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells

Sara J. Prest;Felicity E. B. May;Bruce R. Westley.
The FASEB Journal (2002)

235 Citations

Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer: an immunohistochemical study

J. A. Henry;J. A. Henry;Anne L. McCarthy;B. Angus;B. R. Westley.
Cancer (1990)

189 Citations

Insulin Receptor Substrate-1 Expression Is Regulated by Estrogen in the MCF-7 Human Breast Cancer Cell Line

Claire A. Molloy;Felicity E.B. May;Bruce R. Westley.
Journal of Biological Chemistry (2000)

187 Citations

Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling

Sylvie Rodrigues;Elisabeth Van Aken;Saskia Van Bocxlaer;Samir Attoub.
The FASEB Journal (2003)

166 Citations

Structure of mammalian trefoil factors and functional insights.

L Thim;F E B May.
Cellular and Molecular Life Sciences (2005)

161 Citations

Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells.

Bruce R. Westley;Felicity E.B. May.
Nucleic Acids Research (1987)

159 Citations

Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines.

B. Westley;F. E. B. May;A. M. C. Brown;A. Krust.
Journal of Biological Chemistry (1984)

156 Citations

NCL‐CB11, a new monoclonal antibody recognizing the internal domain of the c‐erbB‐2 oncogene protein effective for use on formalin‐fixed, paraffin‐embedded tissue

Ian P. Corbett;James A. Henry;Brian Angus;Caroline J. Watchorn.
The Journal of Pathology (1990)

149 Citations

If you think any of the details on this page are incorrect, let us know.